Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Short-term Investments (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Short-term Investments for 6 consecutive years, with $30.3 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 72.17% to $30.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.3 million through Dec 2025, down 72.17% year-over-year, with the annual reading at $30.3 million for FY2025, 72.17% down from the prior year.
  • Short-term Investments for Q4 2025 was $30.3 million at Strata Critical Medical, down from $53.2 million in the prior quarter.
  • The five-year high for Short-term Investments was $303.2 million in Q2 2021, with the low at $30.3 million in Q4 2025.
  • Average Short-term Investments over 5 years is $144.1 million, with a median of $132.3 million recorded in 2023.
  • The sharpest move saw Short-term Investments skyrocketed 261247.41% in 2021, then crashed 77.04% in 2022.
  • Over 5 years, Short-term Investments stood at $279.4 million in 2021, then crashed by 46.04% to $150.7 million in 2022, then decreased by 8.28% to $138.3 million in 2023, then dropped by 21.34% to $108.8 million in 2024, then plummeted by 72.17% to $30.3 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $30.3 million, $53.2 million, and $54.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.